GL1X · GenesisL1 explorer

Research workbench

Ternary complex of the mixed lineage leukaemia (MLL1) set domain with the cofactor product S-adenosylhomocysteine and histone peptide.

Analyse Ternary complex of the mixed lineage leukaemia (MLL1) set domain with the… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2W5Z
Type
protein
Length
188 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone-lysine N-methyltransferase hrx; Histone peptide
EC
2.1.1.43
UniProt
Q03164
Ligands
SAH, ZN
Pockets
2 · best druggability 0.48

Structure

x-ray diffraction · 2 distinct chains · 18% helix, 28% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone-lysine N-methyltransferase hrx (EC 2.1.1.43)protein18019% helix, 28% strandQ03164
CHistone peptide (EC 2.1.1.43)protein80% helix, 13% strand—

Ligands and binding sites

  • SAH · S-adenosyl-L-homocysteine · ligand · chains A, C
  • ZN · Zinc ion · metal · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11890.480.7622SAH
2690.360.7714empty

Interfaces

1 interface between chains.

  • A–C · 713 Ų buried · 11 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 modified (methylation).

Compared structures

  • 2W5Z · Ternary Complex of the Mixed Lineage Leukaemia (MLL1) SET Domain with the cofactor… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.